US diagnostics firm to invest €10m in east Clare site
EU Commissioner-designate Michael McGrath
with Beckman Coulter Diagnostics vice president of operations Orlaith Lawler, and president Kevin O’Reilly. Picture: Arthur Ellis
US biomedical firm Beckman Coulter Diagnostics has announced a €10m investment in its site in Co Clare, which will go towards upgrading the facility’s infrastructure, boosting both efficiency and capacity.
The California headquartered company employs more than 11,000 people worldwide — 550 of which are located at its east Clare site.



